TheraRadar
← Back
Data updated: Mar 29, 2026

Apotex

CardiovascularOncologyNeurology
Generics

Apotex is a generic drug manufacturer focused on Cardiovascular, Oncology, Neurology. Key products include IVRA.

1964
Since
267
Drugs
-
Trials
2762
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 34%
22 drugs
Oncology 18%
12 drugs
Neurology 18%
12 drugs
Infectious Disease 18%
12 drugs
Dermatology 11%
7 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...